HIPK2 is largely expressed in human primary MYCN amplification (MNA) neuroblastoma tissues and its expression is induced by MYCN, whose inactivation inhibits HIPK2 and impairs p53Ser46 phosphorylation and apoptosis [46]. The gene discussed is MYCN; the disease is neuroblastoma.